Rigel Provides Business Update and 2026 Outlook
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues…
Read More
The Times Of Bengal
For You Forever Yours
Trybe Announces $30M Series A Investment From Five Elms Capital
LONDON, Jan. 12, 2026 /PRNewswire/ — Trybe, a leading provider of spa, bathhouse, leisure, and activity management software, today announced…
Read More
PureHealth Research Redefines the Best Supplements for Prostate Health With Clinical-Grade Formulations
MANASSAS, Va., Jan. 12, 2026 /PRNewswire/ — PureHealth Research announces its continued commitment to setting new standards for the best…
Read More
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
– RC148 is a novel PD-1/VEGF bispecific antibody being evaluated in multiple advanced solid tumors including certain lung cancers NORTH…
Read More
EQT Life Sciences backs Kinaset Therapeutics’ USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases
EQT Life Sciences invests in U.S.-based Kinaset Therapeutics – a clinical-stage biopharma company developing a novel and differentiated inhaled therapeutic…
Read More
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan USA – English USA – Nederlands USA – Français USA – English USA – Deutsch
The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO…
Read More
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro grants Novartis an exclusive worldwide license to develop SciNeuro’s novel antibody…
Read More
Global Sports Nutrition Market Expanding at 8.18% CAGR to Cross USD 53.42 Billion by 2031 according to a 2026 Mordor Intelligence Report
HYDERABAD, India, Jan. 12, 2026 /PRNewswire/ — According to Mordor Intelligence, the sports nutrition market size is valued at USD…
Read More
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
EXTON, Pa., Jan. 12, 2026 /PRNewswire/ — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for…
Read More
Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones
FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date…
Read More
